Invasive Mold Infections After Chimeric Antigen Receptor-Modified T-Cell Therapy: A Case Series, Review of the Literature, and Implications for Prophylaxis

被引:74
作者
Haider, Ghady [1 ,2 ]
Dorritie, Kathleen [1 ,3 ]
Farah, Rafic [3 ]
Bogdanovich, Tatiana [2 ]
Nguyen, M. Hong [1 ,2 ]
Samanta, Palash [2 ]
机构
[1] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
[2] Univ Pittsburgh, Med Ctr, Div Infect Dis, Pittsburgh, PA USA
[3] Univ Pittsburgh, Med Ctr, Div Hematol & Oncol, Pittsburgh, PA USA
关键词
CAR-T-cell; fungal infections; neutropenia; prophylaxis; steroids; FLUCONAZOLE; EPIDEMIOLOGY; POSACONAZOLE; RISK;
D O I
10.1093/cid/ciz1127
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Data on invasive mold infections (IMIs) after chimeric antigen receptor-modified T-cell (CAR-T-cell) therapy are limited. We describe 2 patients with post-CAR-T-cell IMI (Fusarium, Mucorales) and review the published literature. We propose strategies to prevent IMIs in patients, based on the IMI rate and presence of neutropenia or steroid use.
引用
收藏
页码:672 / 676
页数:5
相关论文
共 16 条
[1]   Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia [J].
Cornely, Oliver A. ;
Maertens, Johan ;
Winston, Drew J. ;
Perfect, John ;
Ullmann, Andrew J. ;
Walsh, Thomas J. ;
Helfgott, David ;
Holowiecki, Jerzy ;
Stockelberg, Dick ;
Goh, Yeow-Tee ;
Petrini, Mario ;
Hardalo, Cathy ;
Suresh, Ramachandran ;
Angulo-Gonzalez, David .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (04) :348-359
[2]   Micafungin versus posaconazole prophylaxis in acute leukemia or myelodysplastic syndrome: A randomized study [J].
Epstein, David J. ;
Seo, Susan K. ;
Huang, Yao-Ting ;
Park, Jay H. ;
Klimek, Virginia M. ;
Berman, Ellin ;
Tallman, Martin S. ;
Frattini, Mark G. ;
Papanicolaou, Genovefa A. .
JOURNAL OF INFECTION, 2018, 77 (03) :227-234
[3]   Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: a systematic review and meta-analysis of randomised controlled trials [J].
Ethier, M. C. ;
Science, M. ;
Beyene, J. ;
Briel, M. ;
Lehrnbecher, T. ;
Sung, L. .
BRITISH JOURNAL OF CANCER, 2012, 106 (10) :1626-1637
[4]  
FAUCI AS, 1976, CLIN EXP IMMUNOL, V24, P54
[5]   Early and late hematologic toxicity following CD19 CAR-T cells [J].
Fried, Shalev ;
Avigdor, Abraham ;
Bielorai, Bella ;
Meir, Amilia ;
Besser, Michal J. ;
Schachter, Jacob ;
Shimoni, Avichai ;
Nagler, Arnon ;
Toren, Amos ;
Jacoby, Elad .
BONE MARROW TRANSPLANTATION, 2019, 54 (10) :1643-1650
[6]   Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy [J].
Hill, Joshua A. ;
Li, Daniel ;
Hay, Kevin A. ;
Green, Margaret L. ;
Cherian, Sindhu ;
Chen, Xueyan ;
Riddell, Stanley R. ;
Maloney, David G. ;
Boeckh, Michael ;
Turtle, Cameron J. .
BLOOD, 2018, 131 (01) :121-130
[7]   Galactomannan and computed tomography - Based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: A prospective feasibility study [J].
Maertens, J ;
Theunissen, K ;
Verhoef, G ;
Verschakelen, J ;
Lagrou, K ;
Verbeken, E ;
Wilmer, A ;
Verhaegen, J ;
Boogaerts, M ;
Van Eldere, J .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (09) :1242-1250
[8]   European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia [J].
Maertens, Johan A. ;
Girmenia, Corrado ;
Bruggemann, Roger J. ;
Duarte, Rafael F. ;
Kibbler, Christopher C. ;
Ljungman, Per ;
Racil, Zdenek ;
Ribaud, Patricia ;
Slavin, Monica A. ;
Cornely, Oliver A. ;
Donnelly, J. Peter ;
Cordonnier, Catherine .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (12) :3221-3230
[9]   Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy [J].
Mahadeo, Kris M. ;
Khazal, Sajad J. ;
Abdel-Azim, Hisham ;
Fitzgerald, Julie C. ;
Taraseviciute, Agne ;
Bollard, Catherine M. ;
Tewari, Priti ;
Duncan, Christine ;
Traube, Chani ;
McCall, David ;
Steiner, Marie E. ;
Cheifetz, Ira M. ;
Lehmann, Leslie E. ;
Mejia, Rodrigo ;
Slopis, John M. ;
Bajwa, Rajinder ;
Kebriaei, Partow ;
Martin, Paul L. ;
Moffet, Jerelyn ;
McArthur, Jennifer ;
Petropoulos, Demetrios ;
Curry, Joan O'Hanlon ;
Featherston, Sarah ;
Foglesong, Jessica ;
Shoberu, Basirat ;
Gulbis, Alison ;
Mireles, Maria E. ;
Hafemeister, Lisa ;
Nguyen, Cathy ;
Kapoor, Neena ;
Rezvani, Katayoun ;
Neelapu, Sattva S. ;
Shpall, Elizabeth J. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (01) :45-63
[10]   Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors [J].
Marr, KA ;
Carter, RA ;
Boeckh, M ;
Martin, P ;
Corey, L .
BLOOD, 2002, 100 (13) :4358-4366